DE60202906D1 - Solubilisierung von 1,3,5-Triazinderivaten mittels Estern von N-Acylaminosäuren - Google Patents

Solubilisierung von 1,3,5-Triazinderivaten mittels Estern von N-Acylaminosäuren

Info

Publication number
DE60202906D1
DE60202906D1 DE60202906T DE60202906T DE60202906D1 DE 60202906 D1 DE60202906 D1 DE 60202906D1 DE 60202906 T DE60202906 T DE 60202906T DE 60202906 T DE60202906 T DE 60202906T DE 60202906 D1 DE60202906 D1 DE 60202906D1
Authority
DE
Germany
Prior art keywords
solubilization
esters
triazine derivatives
acylamino acids
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60202906T
Other languages
English (en)
Other versions
DE60202906T2 (de
Inventor
Didier Candau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8864791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60202906(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE60202906D1 publication Critical patent/DE60202906D1/de
Publication of DE60202906T2 publication Critical patent/DE60202906T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60202906T 2001-06-26 2002-06-21 Solubilisierung von 1,3,5-Triazinderivaten mittels Estern von N-Acylaminosäuren Revoked DE60202906T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108426 2001-06-26
FR0108426A FR2826264B1 (fr) 2001-06-26 2001-06-26 Solubilisation de derives 1,3,5 triazine par des esters n-acyles d'acide amine

Publications (2)

Publication Number Publication Date
DE60202906D1 true DE60202906D1 (de) 2005-03-17
DE60202906T2 DE60202906T2 (de) 2006-06-08

Family

ID=8864791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202906T Revoked DE60202906T2 (de) 2001-06-26 2002-06-21 Solubilisierung von 1,3,5-Triazinderivaten mittels Estern von N-Acylaminosäuren

Country Status (15)

Country Link
US (1) US6509008B1 (de)
EP (1) EP1269980B1 (de)
JP (1) JP2003026559A (de)
KR (1) KR20030001256A (de)
CN (1) CN1394592A (de)
AT (1) ATE288739T1 (de)
AU (1) AU765369B2 (de)
BR (1) BR0202397A (de)
CA (1) CA2389771A1 (de)
DE (1) DE60202906T2 (de)
DK (1) DK1269980T3 (de)
ES (1) ES2237654T3 (de)
FR (1) FR2826264B1 (de)
PL (1) PL354644A1 (de)
RU (1) RU2002116952A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50104611D1 (de) * 2000-04-12 2004-12-30 Bitop Ag Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
AU2001295469A1 (en) * 2000-08-18 2002-03-04 Bitop Gesellschaft Fur Biotechnische Optimierung Mbh Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols
US20040202623A1 (en) * 2003-03-14 2004-10-14 L'oreal S.A. POSS containing cosmetics and personal care products
US20050008588A1 (en) * 2003-06-05 2005-01-13 L'oreal Aminoarylvinyl-s-triazine compounds and uses thereof
FR2855755B1 (fr) * 2003-06-05 2007-09-07 Oreal Utilisation d'au moins un filtre de la lumiere bleue pour preserve le capital de carotenoides endogenes de la peau; nouveaux filtres de la lumiere bleue; compositions cosmetiques
US20050036958A1 (en) * 2003-08-13 2005-02-17 Jianxun Feng Dental bleaching
TWI337086B (en) * 2003-09-03 2011-02-11 Hisamitsu Pharmaceutical Co Transdermal formulation containing nonsteroidal antiinflammatory drug
US20050281763A1 (en) * 2004-06-17 2005-12-22 Yasuko Suginaka Personal care compositions comprising sparingly soluble solid oily components and solvents thereof
FR2872418B1 (fr) * 2004-07-02 2007-06-08 Oreal Compositions photoprotectrices contenant un filtre triazine solubilise par un melange d'un derive arylalkyl benzoate d'une huile amidee; utilisations en cosmetique
FR2872420B1 (fr) * 2004-07-02 2007-04-13 Oreal Compositions contenant un derive de triazine, une huile amidee et un melange eutectique n-butylphthalimide/ isopropylphthalimide; utilisations en cosmetique
US7368105B2 (en) * 2004-07-02 2008-05-06 L'oreal Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate/bis-resorcinyl triazine compounds and photoprotective compositions comprised thereof
EP1796622B1 (de) * 2004-07-02 2008-01-23 L'oreal Triazinderivat, amid-basiertes öl und ein eutektisches gemisch aus n-butyl-phthalimid/isopropylphthalimid enthaltende kosmetische zusammensetzungen
US9717931B2 (en) 2004-07-02 2017-08-01 L'oreal Solubilization of triazine UV-screening agents with arylalkyl benzoate compounds/amide-based oils and photoprotective compositions comprised thereof
US8323624B2 (en) 2004-09-02 2012-12-04 L'oreal S-triazine sunscreens bearing hindered para-aminobenzalmalonate/para-aminobenzalmalonamide and aminobenzoate/aminobenzamide substituents
ATE510828T1 (de) * 2004-09-02 2011-06-15 Oreal S-triazinverbindungen besitzend zwei substituenten ausgewählt aus der gruppe von sperrigen para-aminobenzalmalonat- und para- aminobenzalmalonamidgruppen und einem aminobenzoatesubstituenten, deren zusammensetzungen und verwendungen.
EP1794233A1 (de) * 2004-09-13 2007-06-13 L'oreal Poss-haltige kosmetische zusammensetzungen mit verbesserter dauerhaftigkeit und/oder geschmeidigkeit und verfahren zur herstellung von verbesserten kosmetischen zusammensetzungen
US20070196294A1 (en) * 2006-02-03 2007-08-23 L'oreal Photostable sunscreen compositions comprising dibenzoylmethane compound UV-A filters and s-triazine compounds
FR2896988B1 (fr) * 2006-02-03 2008-03-14 Oreal Compositions contenant un filtre uv-b du type ester de l'acide cinnamique et un derive de s-triazine ; procede de photostabilisation d'un filtre uv-b du type ester de l'acide cinnamique
US20090114355A1 (en) * 2007-11-06 2009-05-07 Honeywell International Inc. Organic fluorescent compositions
DE102008041918A1 (de) * 2008-09-09 2010-03-11 Evonik Degussa Gmbh Silanolkondensationskatalysatoren zur Vernetzung von gefüllten und ungefüllten Polymer-Compounds
FR2947724B1 (fr) 2009-07-10 2012-01-27 Oreal Materiau composite comprenant des filtres uv et des particules plasmoniques et utilisation en protection solaire
JP6574191B2 (ja) * 2014-02-13 2019-09-11 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se 浸透促進剤としてのカプリロイルアラニンエチルエステル
TWI630930B (zh) 2014-02-27 2018-08-01 久光製藥股份有限公司 含有酮洛芬的貼劑
IT202000030185A1 (it) 2020-12-09 2022-06-09 Prod Gianni S R L Alchilesteri di lipoamminoacidi quali spf boosters

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
FR2315991A1 (fr) 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
FR2416008A1 (fr) 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
DE3206398A1 (de) 1982-02-23 1983-09-01 Basf Ag, 6700 Ludwigshafen S-triazinderivate und ihre verwendung als lichtschutzmittel
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
FR2674850B1 (fr) 1991-04-04 1993-07-02 Oreal Derives s-triaziniques portant des substituants benzalmalonates, compositions cosmetiques filtrantes les contenant et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet.
FR2674851B1 (fr) 1991-04-04 1995-02-10 Oreal Derives s-triaziniques portant des substituants benzylidene camphre, compositions cosmetiques filtrantes et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet.
IT1247973B (it) 1991-06-04 1995-01-05 Sigma Prod Chim Derivati di 1,3,5-triazina, loro preparazione e uso come filtri solari
FR2677543B1 (fr) 1991-06-13 1993-09-24 Oreal Composition cosmetique filtrante a base d'acide benzene 1,4-di(3-methylidene-10-camphosulfonique) et de nanopigments d'oxydes metalliques.
FR2677544B1 (fr) 1991-06-14 1993-09-24 Oreal Composition cosmetique contenant un melange de nanopigments d'oxydes metalliques et de pigments melaniques.
FR2680683B1 (fr) 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante contenant un polymere filtre a structure hydrocarbonee et une silicone filtre.
IT1255729B (it) 1992-05-19 1995-11-15 Giuseppe Raspanti Derivati di s-triazina come agenti fotostabilizzanti
DE59509233D1 (de) 1994-02-24 2001-06-13 Haarmann & Reimer Gmbh Kosmetische und dermatologische zubereitungen, enthaltend phenylen-1,4-bisbenzimidiazolesulfonsäuren
JPH07277937A (ja) * 1994-04-01 1995-10-24 Ajinomoto Co Inc 化粧用粉体およびそれを含有する化粧料
GB9515048D0 (en) 1995-07-22 1995-09-20 Ciba Geigy Ag Sunscreen compositions
FR2739555B1 (fr) 1995-10-04 1998-01-02 Oreal Compositions cosmetiques photoprotectrices contenant des nanopigments de tio2 et un acylaminoacide
DE19543730A1 (de) 1995-11-23 1997-05-28 Ciba Geigy Ag Bis-Resorcinyl-Triazine
FR2744721B1 (fr) 1996-02-12 1999-06-18 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations
IT1283295B1 (it) 1996-03-22 1998-04-16 3V Sigma Spa Filtri solari
DE19624455C2 (de) * 1996-06-20 1998-08-27 Henkel Kgaa Sonnenschutzmittel in Form von O/W-Mikroemulsionen
FR2757163B1 (fr) 1996-12-13 1999-02-05 Oreal Nouveaux derives insolubles de s-triazine, leur procede de preparation, compositions les contenant et leurs utilisations
US5976512A (en) 1997-03-03 1999-11-02 Roche Vitamins Inc. Symetrical hydroxyphenyl-s-triazine compositions
EP0863145B1 (de) * 1997-03-03 2003-10-01 F. Hoffmann-La Roche Ag Lichtschutzmittel
EP0878469B1 (de) 1997-05-16 2004-10-27 Ciba SC Holding AG Resorcinyl-Triazine
DE19726184A1 (de) 1997-06-20 1998-12-24 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten
GB9715751D0 (en) 1997-07-26 1997-10-01 Ciba Geigy Ag Formulations
DE19755649A1 (de) 1997-12-15 1999-06-17 Basf Ag Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen
TW553747B (en) * 1997-10-30 2003-09-21 Ajinomoto Kk Nonionic surfactant
TWI225793B (en) * 1997-12-25 2005-01-01 Ajinomoto Kk Cosmetic composition
JPH11189522A (ja) * 1997-12-25 1999-07-13 Ajinomoto Co Inc 化粧料及び皮膚外用剤
EP0933376B1 (de) 1998-01-02 2003-08-20 F. Hoffmann-La Roche Ag Silanyltriazine als Lichtschutzmittel
DE19828463A1 (de) 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
DE19855649A1 (de) 1998-12-03 2000-06-08 Basf Ag Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
DE19910477A1 (de) * 1999-03-10 2000-09-14 Beiersdorf Ag Verwendung von Octocrylen zur Solubilisierung von 2,4-Bis-{[4-(2-Ethyl-hexyloxy-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin in kosmetischen oder dermatologischen Lichtschutzmitteln
JP3802288B2 (ja) * 1999-04-16 2006-07-26 味の素株式会社 油性原料組成物
FR2796550B1 (fr) 1999-07-21 2003-05-09 Asepta Lab Preparations et applications d'esters de n-acylaminoacides

Also Published As

Publication number Publication date
ES2237654T3 (es) 2005-08-01
CA2389771A1 (fr) 2002-12-26
EP1269980B1 (de) 2005-02-09
JP2003026559A (ja) 2003-01-29
RU2002116952A (ru) 2004-01-10
EP1269980A1 (de) 2003-01-02
KR20030001256A (ko) 2003-01-06
US6509008B1 (en) 2003-01-21
BR0202397A (pt) 2003-04-29
PL354644A1 (en) 2002-12-30
ATE288739T1 (de) 2005-02-15
AU4883902A (en) 2003-01-02
CN1394592A (zh) 2003-02-05
DE60202906T2 (de) 2006-06-08
FR2826264A1 (fr) 2002-12-27
FR2826264B1 (fr) 2005-03-04
AU765369B2 (en) 2003-09-18
DK1269980T3 (da) 2005-05-17

Similar Documents

Publication Publication Date Title
DE60202906D1 (de) Solubilisierung von 1,3,5-Triazinderivaten mittels Estern von N-Acylaminosäuren
MX9202287A (es) Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
CO5580746A2 (es) Derivados de fenil-piperazina como inhibidores de la reabsorcion de la serotonina
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
FR2827511B1 (fr) Composition autobronzante contenant un ester n-acyle d'acide amine et un agent autobronzant
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
HUP0002942A2 (hu) Szerin proteáz inhibitor hatású peptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
KR960702831A (ko) 이황화물(Disulphides)
KR910019612A (ko) 옥살릴아미노산 유도체, 이의 제조방법 및 프롤린 하이드록실라제 억제용 약제로서의 이의 용도
SE9203825D0 (sv) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
HK1094680A1 (en) Anti-inflammatory agents
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
DK0434570T3 (da) Steroid-forbindelser med en substitueret thioethylgruppe i position 10, deres fremstilling og mellemprodukter herfra, forbindelserne anvendt som lægemidler samt farmaceutiske præparater med indhold heraf
ATE179169T1 (de) Prostaglandinanaloge
FR2806726B1 (fr) Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues
DK1205476T3 (da) Fremgangsmåde til syntese af N-(mercaptoacyl)-aminosyrederivater ud fra alfa-substituerede acrylsyrer
DE3863214D1 (de) Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK1322321T3 (da) Anvendelse af S-[2,3-bispalmitoyloxy-(2RS)propyl]cysteinyl-GNNDESNISFKEK (MALP-2)
IL102702A (en) OPTICALLY ACTIVE g-HALO- 2-AMINOALKANECARBOXYLIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE FOR THE PREPARATION OF OPTICALLY ACTIVE PHOSPHORUS-CONTAINING a-AMINO ACIDS
DE50000905D1 (de) Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen
HUP9902666A2 (hu) Nitronvegyületek, valamint ezeket a vegyületeket tartalmazó szemgyulladás kezelésére alkalmas gyógyszerkészítmények

Legal Events

Date Code Title Description
8331 Complete revocation
8363 Opposition against the patent